Arrowhead Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ARWR Nasdaq 2834 http://arrowheadpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arrowhead Pharmaceuticals Inc

Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-C3 for Treatment of Complement Mediated Diseases - Oct 12th, 2021 8:00 pm
Arrowhead Pharmaceuticals Initiates Phase 2b Study of ARO-APOC3 for Treatment of Mixed Dyslipidemia - Sep 30th, 2021 11:30 am
Arrowhead Pharmaceuticals to Participate in Upcoming October 2021 Conferences - Sep 29th, 2021 11:30 am
Arrowhead Earns $10 Million Phase 1 Milestone Payment - Sep 28th, 2021 11:30 am
Despite shrinking by US$371m in the past week, Arrowhead Pharmaceuticals (NASDAQ:ARWR) shareholders are still up 804% over 5 years - Sep 13th, 2021 12:11 pm
Arrowhead Pharmaceuticals to Participate in Upcoming September 2021 Conferences - Sep 1st, 2021 11:30 am
Is Arrowhead Pharmaceuticals (ARWR) A Good Stock To Buy Now? - Aug 27th, 2021 5:51 am
ARWR: New Program Targeting Complement C3 Highlights Expanding Pipeline… - Aug 10th, 2021 11:12 am
Arrowhead Pharmaceuticals, inc (ARWR) Q3 2021 Earnings Call Transcript - Aug 6th, 2021 6:01 am
Arrowhead Pharmaceuticals Reports Fiscal 2021 Third Quarter Results - Aug 5th, 2021 8:00 pm
Arrowhead Pharmaceuticals Receives Breakthrough Therapy Designation from U.S. FDA for ARO-AAT for the Treatment of Alpha-1 Antitrypsin Deficiency Associated Liver Disease - Jul 29th, 2021 11:30 am
Here is What Hedge Funds Think About Arrowhead Pharmaceuticals Inc. (ARWR) - Jul 21st, 2021 2:06 pm
Arrowhead Pharmaceuticals: Buy the Dip? - Jul 19th, 2021 2:46 pm
Arrowhead Pharmaceuticals to Webcast Fiscal 2021 Third Quarter Results - Jul 14th, 2021 11:30 am
Arrowhead Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Jul 14th, 2021 11:30 am
10 Best Pharmaceutical Stocks to Buy According to Billionaire Joseph Edelman - Jul 6th, 2021 3:49 pm
Arrowhead's ARO-HIF2 Shows Early Signs Of Efficacy In Type Of Kidney Cancer - Jul 6th, 2021 2:39 pm
Arrowhead Announces Positive Interim Results from Phase 1b Study of ARO-HIF2 for Treatment of Clear Cell Renal Cell Carcinoma - Jul 6th, 2021 11:30 am
Arrowhead Stock Plunges, Alector Stock Surges On Drug News - Jul 2nd, 2021 4:22 pm
Here's Why Arrowhead Pharmaceuticals Stock Is Getting Hammered Today - Jul 2nd, 2021 4:18 pm